Wet AMD sufferers unaware of pre-existing AMD

Article

Current screening of patients with age-related macular degeneration (AMD) does not sufficiently identify those patients most at risk of wet AMD and hence is unable to prevent its development, according to a report published in the June 2008 issue of Eye.

Current screening of patients with age-related macular degeneration (AMD) does not sufficiently identify those patients most at risk of wet AMD and hence is unable to prevent its development, according to a report published in the June 2008 issue of Eye.

Itay Chowers, MD of the Hadassah-Hebrew University Medical Center, Israel and colleagues conducted a retrospective analysis of NVAMD subjects (n=268) and compared characteristics between those subjects who were aware of their AMD before the NVAMD diagnosis (n=83), and those who were not (n=185).

The researchers found that there were no significant differences between the two groups in terms of demographic characteristics, visual acuity, lesion size and lesion composition. Patients who were not previously aware of their AMD were more likely to have a history of smoking (41%) than those who were aware (26%); patients with a positive family history of AMD were more likely to be aware of their own AMD before the NVAMD diagnosis (20%) than those who did not (10%).

The team concluded that the majority of patients receiving an NVAMD diagnosis were previously unaware that they had AMD, although early AMD detection may not entail detection of treatable choroidal neovascularization lesions.

Related Videos
Ramin Tadayoni, MD, speaks with Sheryl Stevenson
Jennifer I. Lim, MD, FARVO, FASRS, Director of Retina Service, University of Illinois at Chicago
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center
Carl D. Regillo, MD, FACS, FASRS, Chief of Retina Service, Wills Eye Hospital, Philadelphia, PA
Arshad Khanani, MD, MA FASRS, on a virtual call
Diana Do, MD, Professor of Ophthalmology, Byers Eye Institute, Stanford University, discusses the PHOTON study results as presented AAO
Penny A Asbell, MD, FACS speaks at the 2023 AAO meeting
© 2024 MJH Life Sciences

All rights reserved.